The efficacy and safety of donafenib as postoperative adjuvant therapy in patients at high risk of recurrence following radical resection of hepatocellular carcinoma (HCC): A multicenter retrospective ...

Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...

Doctor showing tablet to patient. Management of metastatic renal cell carcinoma should be highly individualized, according to investigators. Preoperative systemic therapy does not lead to worse ...

While lobectomy is the surgical gold standard for early-stage NSCLC, some patients will continue to need pneumonectomy to achieve radical resection. Historically, the use of adjuvant and neoadjuvant ...

Breaking News: Trump administration impacts continue to roil the life sciences sector Home » Autologous B-cell therapy WFX-001 corrects systemic α-GAL enzyme deficiency in vivo ...

Patients with clear cell renal cell carcinoma speak to their experiences with systemic treatments. Chung-Han Lee, MD: Mr Lewis and Ms Uranga, tell me a little about the systemic treatments that you’ve ...

Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion Virus-directed ...

Please provide your email address to receive an email when new articles are posted on . Transurethral resection of bladder tumor plus systemic therapy induced clinical complete response among a large ...